XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Jan. 30, 2022 $ 53,295 $ 207,884 $ (51) $ 261,128
Balance (in Shares) at Jan. 30, 2022 11,922,000      
Net income   13,566   13,566
Unrealized gain loss on defined benefit plan, net of tax     47 47
Cash dividends paid   (7,117)   (7,117)
Purchase and retirement of common stock $ (2,751) (6,608)   (9,359)
Purchase and retirement of common stock (in Shares) (598,000)      
Restricted stock grants, net of forfeitures $ (102)     (102)
Restricted stock grants, net of forfeitures (in Shares) 97,000      
Restricted stock compensation cost $ 963     963
Performance-based restricted stock units costs 463     463
Balance at Oct. 30, 2022 $ 51,868 207,725 (4) 259,589
Balance (in Shares) at Oct. 30, 2022 11,421,000      
Balance at Jul. 31, 2022 $ 53,853 210,994 (19) 264,828
Balance (in Shares) at Jul. 31, 2022 11,959,000      
Net income   4,841   4,841
Unrealized gain loss on defined benefit plan, net of tax     15 15
Cash dividends paid   (2,323)   (2,323)
Purchase and retirement of common stock $ (2,436) (5,787)   (8,223)
Purchase and retirement of common stock (in Shares) (530,000)      
Restricted stock grants, net of forfeitures (in Shares) (8,000)      
Restricted stock compensation cost $ 297     297
Performance-based restricted stock units costs 154     154
Balance at Oct. 30, 2022 $ 51,868 207,725 (4) 259,589
Balance (in Shares) at Oct. 30, 2022 11,421,000      
Balance at Jan. 29, 2023 $ 50,770 184,386 865 $ 236,021
Balance (in Shares) at Jan. 29, 2023 11,197,000     11,197,000
Net income   9,272   $ 9,272
Unrealized gain loss on defined benefit plan, net of tax     (159) (159)
Cash dividends paid   (7,228)   (7,228)
Purchase and retirement of common stock $ (2,952) (8,851)   $ (11,803)
Purchase and retirement of common stock (in Shares) (620,000)     620,634
Restricted stock grants, net of forfeitures $ (150)     $ (150)
Restricted stock grants, net of forfeitures (in Shares) 95,000      
Restricted stock compensation cost $ 1,255     1,255
Performance-based restricted stock units costs 580     580
Balance at Oct. 29, 2023 $ 49,503 177,579 706 $ 227,788
Balance (in Shares) at Oct. 29, 2023 10,672,000     10,672,000
Balance at Jul. 30, 2023 $ 49,561 175,348 759 $ 225,668
Balance (in Shares) at Jul. 30, 2023 10,819,000      
Net income   7,038   7,038
Unrealized gain loss on defined benefit plan, net of tax     (53) (53)
Cash dividends paid   (2,373)   (2,373)
Purchase and retirement of common stock $ (700) (2,434)   (3,134)
Purchase and retirement of common stock (in Shares) (147,000)      
Restricted stock compensation cost $ 449     449
Performance-based restricted stock units costs 193     193
Balance at Oct. 29, 2023 $ 49,503 $ 177,579 $ 706 $ 227,788
Balance (in Shares) at Oct. 29, 2023 10,672,000     10,672,000